These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8285196)

  • 21. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinin kinetics during different dialysis protocols with AN69 dialyser in ACEI-treated patients.
    Van der Niepen P; Sennesael JJ; Verbeelen DL
    Nephrol Dial Transplant; 1995; 10(9):1689-95. PubMed ID: 8559490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phagocytic activity of leukocytes induced by different dialyzer membranes.
    Vanholder R; Dhondt A; Van Landschoot N; Waterloos MA; Ringoir S
    Contrib Nephrol; 1989; 74():86-90. PubMed ID: 2518453
    [No Abstract]   [Full Text] [Related]  

  • 24. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C; Heintz B; Sieberth HG
    Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyrogen retention by highly permeable synthetic membranes during in vitro dialysis.
    Lonnemann G; Sereni L; Lemke HD; Tetta C
    Artif Organs; 2001 Dec; 25(12):951-60. PubMed ID: 11843762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods.
    Tsuchida K; Takemoto Y; Yamagami S; Edney H; Niwa M; Tsuchiya M; Kishimoto T; Shaldon S
    Nephron; 1997; 75(4):438-43. PubMed ID: 9127331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
    Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
    Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dialysis membranes on the kinetics of tumor necrosis factor-alpha production by peripheral mononuclear cells in chronic hemodialysis patients.
    Kushihata S; Yorioka N; Oda H; Ye XF; Yamakido M
    Int J Artif Organs; 1998 Jul; 21(7):384-90. PubMed ID: 9745992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of cytokines and adhesion molecules in stable hemodialysis patients: is there an effect of membrane material?
    Hoffmann U; Fischereder M; Marx M; Schweda F; Lang B; Straub RH; Krämer BK
    Am J Nephrol; 2003; 23(6):442-7. PubMed ID: 14583663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AN69: Evolution of the world's first high permeability membrane.
    Thomas M; Moriyama K; Ledebo I
    Contrib Nephrol; 2011; 173():119-129. PubMed ID: 21865784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anaphylactoid reactions during hemodialysis and hemofiltration: role of associating AN69 membrane and angiotensin I-converting enzyme inhibitors.
    Brunet P; Jaber K; Berland Y; Baz M
    Am J Kidney Dis; 1992 May; 19(5):444-7. PubMed ID: 1585932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biocompatibility of hemodialysis membranes: a study in healthy subjects.
    Gutierrez A; Alvestrand A; Bergström J; Beving H; Lantz B; Henderson LW
    Blood Purif; 1994; 12(2):95-105. PubMed ID: 7826580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postdialysis fatigue: lack of effect of a biocompatible membrane.
    Sklar AH; Beezhold DH; Newman N; Hendrickson T; Dreisbach AW
    Am J Kidney Dis; 1998 Jun; 31(6):1007-10. PubMed ID: 9631846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaphylactoid reactions in hemodialysis patients treated with the AN69 dialyzer.
    Parnes EL; Shapiro WB
    Kidney Int; 1991 Dec; 40(6):1148-52. PubMed ID: 1762316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
    Vanholder RC; Ringoir SM
    Blood Purif; 1990; 8(1):32-44. PubMed ID: 2198890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1.
    Lonnemann G; Koch KM; Shaldon S; Dinarello CA
    J Lab Clin Med; 1988 Jul; 112(1):76-86. PubMed ID: 3260615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in mononuclear cell tumour necrosis factor-alpha (TNF-alpha) response in patients on long term cuprophane haemodialysis.
    Annenkov AY; Strokov AG; Baranova FS
    Clin Exp Immunol; 1992 Oct; 90(1):49-55. PubMed ID: 1395100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour necrosis factor does not increase during routine cuprophane haemodialysis in healthy well-nourished patients.
    Davenport A; Crabtree J; Androjna C; Will EJ; Davison AM
    Nephrol Dial Transplant; 1991; 6(6):435-9. PubMed ID: 1876285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production and kinetics of interleukin-1 in hemodialysis. In vivo and in vitro study.
    Donati D; Degiannis D; Homer L; Raska K; Raskova J
    Am J Nephrol; 1991; 11(6):451-8. PubMed ID: 1819211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reprocessed (high-flux) Polyflux dialyzers resist trans-membrane endotoxin passage and attenuate inflammatory markers.
    Teehan GS; Guo D; Perianayagam MC; Balakrishnan VS; Pereira BJ; Jaber BL
    Blood Purif; 2004; 22(4):329-37. PubMed ID: 15240988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.